EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Intensive short term therapy for adults with histologically aggressive disseminated non-Hodgkins lymphomas Evaluation of feasibility and results in a prospective multicenter trial



Intensive short term therapy for adults with histologically aggressive disseminated non-Hodgkins lymphomas Evaluation of feasibility and results in a prospective multicenter trial



Blood 84(10 SUPPL 1): 384A




(PDF emailed within 1 workday: $29.90)

Accession: 031975653

Download citation: RISBibTeXText



Related references

Intensive short term therapy for adults with disseminated intermediate or high grade non-Hodgkins lymphomas Analysis of prognostic factors in a prospective multicenter trial. British Journal of Haematology 93(SUPPL 2): 146-147, 1996

Value of recombinant human granulocyte-colony stimulating factor in the treatment of aggressive non-Hodgkins lymphomas with an intensive weekly chemotherapy schedule An Austrian randomized multicenter trial. Blood 84(10 SUPPL 1): 23A, 1994

Intensive short term therapy for patient with disseminated follicular lymphomas Clinical and molecular results of a single center pilot study. Bone Marrow Transplantation 0(PROGRAM ABSTR ): 145, 1994

CHOP vs ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: Long-term results of a multicenter randomized trial. European Journal of Haematology 57(5): 377-383, 1996

Localized aggressive non-Hodgkins lymphomas 7-year results of the POF 02 trial on 209 patients. Nouvelle Revue Francaise d'Hematologie 35(3): 327, 1993

Localized aggressive non-Hodgkins lymphomas 6-year results of the POF 03 trial on 81 patients. Nouvelle Revue Francaise d'Hematologie 35(3): 327, 1993

Preliminary results of a randomized BNLI trial of CHOP vs CIOP in good prognosis younger patients with histologically aggressive non-Hodgkins lymphoma. Blood 92(10 SUPPL 1 PART 1-2): 620A, Nov 15, 1998

A prospective multicenter response adapted trial on the therapy of non hodgkin lymphomas of high grade malignancy application cop bla imvp 16 and randomized adjuvant radiotherapy concept and preliminary results of the trial. Onkologie 11(1): 30-34, 1988

Early autologous stem cell transplantation versus conventional first-line chemotherapy in high-risk aggressive non-Hodgkins lymphomas An Italian multicenter randomized trial. Blood 96(11 Part 1): 481a, November 16, 2000

Histology and stage stratified therapy offers promising results in primary gastric non-Hodgkins lymphoma Experiences of the German-Austrian prospective multicenter trial. Gastroenterology 114(4 PART 2): A595, April 15, 1998

Therapy of high-grade non-Hodgkins lymphomas The German Multicenter NHL-Consensus Trial B. Onkologie 18(SUPPL 2): 7, 1995

PACEBOM is superior to CHOP in patients with Stage IV histologically aggressive non-Hodgkins lymphoma Results of a British National Lymphoma Investigation Trial. Blood 84(10 SUPPL 1): 384A, 1994

AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation. Clinical Research in Cardiology 97(6): 389-396, 2008

Frontline high-dose therapy with autologous stem cell support in young PTS with disseminated intermediate or high grade lymphomas Evaluation of feasibility and efficacy in consecutive prospective trials. British Journal of Haematology 102(1): 237, July 1, 1998

Feasibility and short-term results of the "plug" technique in inguinal hernia. A prospective evaluation. Annales de Chirurgie 51(6): 627-630, 1997